Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy.
Nature Communications
Rendo, Veronica V; Stoimenov, Ivaylo I; Mateus, André A; Sjöberg, Elin E; Svensson, Richard R; Gustavsson, Anna-Lena AL; Johansson, Lars L; Ng, Adrian A; OʼBrien, Casey C; Giannakis, Marios M; Artursson, Per P; Nygren, Peter P; Cheong, Ian I; Sjöblom, Tobias T
Publication Date: 2020-03-11
Variant appearance in text: SULT1A1: F247L; rs28374453
Effects of the human SULT1A1 polymorphisms on the sulfation of acetaminophen,O-desmethylnaproxen, and tapentadol.
Pharmacological Reports : Pr
Rasool, Mohammed I MI; Bairam, Ahsan F AF; Gohal, Saud A SA; El Daibani, Amal A AA; Alherz, Fatemah A FA; Abunnaja, Maryam S MS; Alatwi, Eid S ES; Kurogi, Katsuhisa K; Liu, Ming-Cheh MC
Publication Date: 2019-04
Variant appearance in text: SULT1A1: F247L; rs28374453
Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.
Oncotarget
Greenawalt, Danielle M DM; Liang, Winnie S WS; Saif, Sakina S; Johnson, Justin J; Todorov, Petar P; Dulak, Austin A; Enriquez, Daniel D; Halperin, Rebecca R; Ahmed, Ambar A; Saveliev, Vladislav V; Carpten, John J; Craig, David D; Barrett, J Carl JC; Dougherty, Brian B; Zinda, Michael M; Fawell, Stephen S; Dry, Jonathan R JR; Byth, Kate K
Publication Date: 2017-11-21
Variant appearance in text: SULT1A1: 739T>C; F247L; rs28374453